|
[1] BRUIX J, SHERMAN M.Management of hepatocellular carcinoma[J].Hepatology, 2005, 42 (5) :1208-1236.
|
|
[2]LIM KC, CHOW PK, ALLEN JC, et al.Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria[J].Br J Surg, 2012, 99 (12) :1622-1629.
|
|
[3]POON RT, FAN ST, LO CM, et al.Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function:implications for a strategy of salvage transplantation[J].Ann Surg, 2002, 235 (3) :373-382.
|
|
[4] MAZZAFERRO V, REGALIA E, DOCI R, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J].N Engl J Med, 1996, 334 (11) :693-699.
|
|
[5]Chinese Societies of Liver Cancer and Clinical Oncology, Chinese Anti-Cancer Association;Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association.Experts consensus on local ablation for liver cancer[J].Chin J Hepatol, 2011, 19 (4) :257-259. (in Chinese) 中国抗癌协会肝癌专业委员会、中国抗癌协会临床肿瘤学协作委员会、中华医学会肝病学分会肝癌学组.肝癌局部消融治疗规范的专家共识[J].中华肝脏病杂志, 2011, 19 (4) :257-259.
|
|
[6]CHEN MS, LI JQ, ZHENG Y, et al.A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J].Ann Surg, 2006, 243 (3) :321-328.
|
|
[7]LLOVET JM, REAL MI, MONTAA X, et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial[J].Lancet, 2002, 359 (9319) :1734-1739.
|
|
[8] LLOVET JM, RICCI S, MAZZAFERRO V, et al.Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med, 2008, 359 (4) :378-390.
|
|
[9]CHENG AL, KANG YK, CHEN Z, et al.Efficacy and safetyof sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncol, 2009, 10 (1) :25-34.
|
|
[10]European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].J Hepatol, 2012, 56 (4) :908-943.
|
|
[11]ZHOU WP, LAI EC, LI AJ, et al.A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma[J].Ann Surg, 2009, 249 (2) :195-202.
|
|
[12]LUO J, PENG ZW, GUO RP, et al.Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas:a prospective nonrandomized analysis[J].Radiology, 2011, 259 (1) :286-295.
|
|
[13]YU WS, GUO RP, SHI M, et al.Efficacy of second stage resection following transcatheter hepatic arterial chemoembolization in patients with hepatocellular carcinoma of hardly radical excision[J].J Sun Yat-Sen Univ:Medical Sciences, 2007, 28 (6) :709-713. (in Chinese) 俞武生, 郭荣平, 石明, 等.难以根治性切除大肝癌经皮肝动脉化疗栓塞术后二期切除的疗效分析[J].中山大学学报:医学科学版, 2007, 28 (6) :709-713.
|
|
[14]LAU WY, LAI EC, LAU SH.The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma:a systematic review[J].Hepatobiliary Pancreat Dis Int, 2009, 8 (2) :124-133.
|
|
[15]ZHONG C, GUO RP, LI JQ, et al.A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma[J].J Cancer Res Clin Oncol, 2009, 135 (10) :1437-1445.
|
|
[16]REN ZG, LIN ZY, XIA JL, et al.Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor:a retrospective control study[J].World J Gastroenterol, 2004, 10 (19) :2791-2794.
|
|
[17]LO CM, LIU CL, CHAN SC, et al.A randomized controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma[J].Ann Surg, 2007, 245 (6) :831-842.
|
|
[18]SUN HC, TANG ZY, WANG L, et al.Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:a randomized clinical trial[J].J Cancer Res Clin Oncol, 2006, 132 (7) :458-465.
|
|
[19]BLOOMSTON M, BINITIE O, FRAIJI E, et al.Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy[J].Am Surg, 2002, 68 (9) :827-831.
|
|
[20]ZHANG YJ, LIANG HH, CHEN MS, et al.Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection:a prospective randomized trial[J].Radiology, 2007, 244 (2) :599-607.
|
|
[21]PENG ZW, ZHANG YJ, CHEN MS, et al.Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma:a prospective randomized trial[J].J Clin Oncol, 2013, 31 (4) :426-432.
|
DownLoad: